Schedule 13G ownership disclosure

SELLAS Life Sciences Group, Inc.

Security class unavailable · CUSIP: 81642T100

Event date: 2018-07-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,275,000
Percent of class
9.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-18-003284
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Jul 23, 2018
Reporting period
Jul 13, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub